Media Summary: Angela Fleischman, M.D., Ph.D., of the University of California, Irvine, You or a loved one has just been diagnosed with a subtype of Jean-Jacques Kiladjian, MD, PhD from Saint-Louis Hospital & Paris Diderot University, Paris, France

Dr Mesa Discusses Exciting Abstracts On Myeloproliferative Neoplasms - Detailed Analysis & Overview

Angela Fleischman, M.D., Ph.D., of the University of California, Irvine, You or a loved one has just been diagnosed with a subtype of Jean-Jacques Kiladjian, MD, PhD from Saint-Louis Hospital & Paris Diderot University, Paris, France Dr. Bradley on Ruxolitinib in Myeloproliferative Neoplasms Claire Harrison, MD, DM, FRCP, FRCPath, from the Guy's and St. Thomas' NHS Foundation Trust, London, UK, gives an overview ...

Photo Gallery

Dr. Mesa Discusses Exciting Abstracts on Myeloproliferative Neoplasms
Dr. Mesa Discusses the Treatment Landscape for MPNs
Dr. Mesa on NCCN Guidelines for MPNs
Expert Discusses Exciting Advances in the MPN Field
An Overview of Myeloproliferative Neoplasms
2017 ASH MHM: Focus on MPN – Ruben Mesa, MD
What are Myeloproliferative Neoplasms? For Patients & Caregivers from Top MPN Specialist
Professor Ruben Mesa: Living with an MPN
Dr. Mesa Gives an Overview of  Upcoming Trials in Myelofibrosis
Dr. Mesa on Upcoming Updates to NCCN Guideline for MPNs
Advances in the science and treatment of MPNs
What's new in myeloproliferative neoplasms?
Sponsored
Sponsored
View Detailed Profile
Dr. Mesa Discusses Exciting Abstracts on Myeloproliferative Neoplasms

Dr. Mesa Discusses Exciting Abstracts on Myeloproliferative Neoplasms

... some of the

Dr. Mesa Discusses the Treatment Landscape for MPNs

Dr. Mesa Discusses the Treatment Landscape for MPNs

Ruben

Sponsored
Dr. Mesa on NCCN Guidelines for MPNs

Dr. Mesa on NCCN Guidelines for MPNs

Ruben A.

Expert Discusses Exciting Advances in the MPN Field

Expert Discusses Exciting Advances in the MPN Field

Angela Fleischman, M.D., Ph.D., of the University of California, Irvine,

An Overview of Myeloproliferative Neoplasms

An Overview of Myeloproliferative Neoplasms

Harry P. Erba, MD, PhD, and Ruben A.

Sponsored
2017 ASH MHM: Focus on MPN – Ruben Mesa, MD

2017 ASH MHM: Focus on MPN – Ruben Mesa, MD

Ruben A.

What are Myeloproliferative Neoplasms? For Patients & Caregivers from Top MPN Specialist

What are Myeloproliferative Neoplasms? For Patients & Caregivers from Top MPN Specialist

You or a loved one has just been diagnosed with a subtype of

Professor Ruben Mesa: Living with an MPN

Professor Ruben Mesa: Living with an MPN

Professor Ruben

Dr. Mesa Gives an Overview of  Upcoming Trials in Myelofibrosis

Dr. Mesa Gives an Overview of Upcoming Trials in Myelofibrosis

Ruben A.

Dr. Mesa on Upcoming Updates to NCCN Guideline for MPNs

Dr. Mesa on Upcoming Updates to NCCN Guideline for MPNs

Ruben A.

Advances in the science and treatment of MPNs

Advances in the science and treatment of MPNs

Ruben

What's new in myeloproliferative neoplasms?

What's new in myeloproliferative neoplasms?

Jean-Jacques Kiladjian, MD, PhD from Saint-Louis Hospital & Paris Diderot University, Paris, France

Key Presentations on Myeloproliferative Neoplasms from Recent Major Conferences

Key Presentations on Myeloproliferative Neoplasms from Recent Major Conferences

Dr

What Makes People with Myeloproliferative Neoplasms Unique?

What Makes People with Myeloproliferative Neoplasms Unique?

Carole Brennan Miller, M.D., head of the

Dr. Mesa on JAKARTA-2 Reanalysis for Myelofibrosis

Dr. Mesa on JAKARTA-2 Reanalysis for Myelofibrosis

Ruben

Dr. Bradley on Ruxolitinib in Myeloproliferative Neoplasms

Dr. Bradley on Ruxolitinib in Myeloproliferative Neoplasms

Dr. Bradley on Ruxolitinib in Myeloproliferative Neoplasms

Update on clinical trials for myeloproliferative neoplasms

Update on clinical trials for myeloproliferative neoplasms

Claire Harrison, MD, DM, FRCP, FRCPath, from the Guy's and St. Thomas' NHS Foundation Trust, London, UK, gives an overview ...

Ruben Mesa, MD on Myelofibrosis (Full Interview)

Ruben Mesa, MD on Myelofibrosis (Full Interview)

Ruben

The most promising novel approaches currently in development for MPNs

The most promising novel approaches currently in development for MPNs

Ruben

What Should You Expect from Your MPN Treatment?  Ruben A. Mesa, MD, FACP

What Should You Expect from Your MPN Treatment? Ruben A. Mesa, MD, FACP

Dr